Organic chemistry: Channelling new treatments for Parkinson’s disease?
Nature Communications
2012년10월24일
The first molecule that is selective for a particular type of ion-channel protein that is implicated in Parkinson’s disease is reported in Nature Communications this week. The chemical compound could prove to be a new drug candidate for the treatment of the disease.
Various subtypes of calcium channels exist in the brain, and calcium channels containing a particular subunit are thought to have a role in Parkinson’s disease. Drugs that selectively target this particular calcium channel subtype may therefore be useful for treating the disease. Selectivity of drugs is known to be important to achieve effective alleviation of symptoms whilst limiting side-effects. Richard Silverman and colleagues screened chemical libraries to identify compounds that bind to the calcium channel that is implicated in Parkinson’s disease. The team then modified the compound to produce a potent and selective inhibitor of the calcium channel subtype.
With further development the work could lead to a new avenue of enquiry for the treatment of Parkinson’s disease.
doi: 10.1038/ncomms2149
리서치 하이라이트
-
10월14일
Climate change: Global energy spending changes in a warming worldNature
-
10월13일
Health: El Niño associated with child undernutrition in the tropicsNature Communications
-
10월12일
Archaeology: Earliest known human use of tobacco revealedNature Human Behaviour
-
10월12일
Sociology: Older adults worldwide exhibit increased, but more nationally focused, prosocial behaviorNature Aging
-
10월7일
Drug discovery: A promising candidate for the treatment of dengueNature
-
9월29일
Genetics: Epigenetic signature specific to identical twins identifiedNature Communications
